Keiko Mizuno

2.2k total citations
94 papers, 1.7k citations indexed

About

Keiko Mizuno is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Keiko Mizuno has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 36 papers in Pulmonary and Respiratory Medicine and 27 papers in Oncology. Recurrent topics in Keiko Mizuno's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (16 papers) and RNA modifications and cancer (15 papers). Keiko Mizuno is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (16 papers) and RNA modifications and cancer (15 papers). Keiko Mizuno collaborates with scholars based in Japan, Greece and Czechia. Keiko Mizuno's co-authors include Hiromasa Inoue, Naohiko Seki, Tomohiro Kumamoto, Hiroko Mataki, Masahiko Ohara, Kazuto Kamikawaji, Naoto Kuroda, Gang‐Hong Lee, Takayuki Suetsugu and Yusuke Goto and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and FEBS Letters.

In The Last Decade

Keiko Mizuno

89 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiko Mizuno Japan 23 926 730 470 463 195 94 1.7k
Christina Selinger Australia 22 864 0.9× 660 0.9× 928 2.0× 726 1.6× 343 1.8× 50 2.1k
Madalina Tuluc United States 24 744 0.8× 630 0.9× 673 1.4× 270 0.6× 403 2.1× 95 1.8k
Omar Hameed United States 23 452 0.5× 445 0.6× 587 1.2× 649 1.4× 355 1.8× 84 1.8k
Katja Gwin United States 18 1.3k 1.4× 1.3k 1.7× 659 1.4× 285 0.6× 256 1.3× 48 2.6k
Xiaochun Fei China 27 634 0.7× 764 1.0× 874 1.9× 384 0.8× 135 0.7× 90 2.2k
Jin‐Hee Ahn South Korea 25 549 0.6× 484 0.7× 938 2.0× 821 1.8× 323 1.7× 115 1.9k
Guido M.J.M. Roemen Netherlands 17 686 0.7× 326 0.4× 530 1.1× 194 0.4× 135 0.7× 29 1.4k
Shuanzeng Wei United States 20 908 1.0× 540 0.7× 504 1.1× 1.0k 2.2× 326 1.7× 73 2.1k
Aglaya G. Iyevleva Russia 22 689 0.7× 482 0.7× 588 1.3× 473 1.0× 90 0.5× 78 1.5k
Ji‐Youn Sung South Korea 21 400 0.4× 221 0.3× 478 1.0× 309 0.7× 355 1.8× 90 1.4k

Countries citing papers authored by Keiko Mizuno

Since Specialization
Citations

This map shows the geographic impact of Keiko Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Mizuno more than expected).

Fields of papers citing papers by Keiko Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Mizuno. The network helps show where Keiko Mizuno may publish in the future.

Co-authorship network of co-authors of Keiko Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Mizuno. A scholar is included among the top collaborators of Keiko Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Mizuno. Keiko Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuyama, Takahiro, Hiroko Uchida, Shunsuke Yasuda, et al.. (2024). Long-term efficacy of mepolizumab on eosinophilic granulomatosis with polyangiitis: a retrospective study. 2(6). 461–472. 1 indexed citations
2.
3.
Matsuyama, Takahiro, et al.. (2023). The Functional Role of Group 2 Innate Lymphoid Cells in Asthma. Biomolecules. 13(6). 893–893. 7 indexed citations
4.
Matsuyama, Takahiro, Shunsuke Yasuda, Akifumi Uchida, et al.. (2023). Improving visual acuity with nivolumab plus ipilimumab plus two cycles of chemotherapy following a diagnosis of lung adenocarcinoma with choroidal metastasis: A case report and literature review. SHILAP Revista de lepidopterología. 12(1). e01262–e01262.
5.
Misono, Shunsuke, Naoko Kikkawa, Takayuki Suetsugu, et al.. (2023). Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets. FEBS Open Bio. 13(9). 1737–1755. 5 indexed citations
7.
Matsuyama, Takahiro, Kentaro Machida, Yasutaka Motomura, et al.. (2021). Long‐acting muscarinic antagonist regulates group 2 innate lymphoid cell‐dependent airway eosinophilic inflammation. Allergy. 76(9). 2785–2796. 22 indexed citations
8.
Misono, Shunsuke, Naohiko Seki, Keiko Mizuno, et al.. (2019). Molecular Pathogenesis of Gene Regulation by the miR-150 Duplex: miR-150-3p Regulates TNS4 in Lung Adenocarcinoma. Cancers. 11(5). 601–601. 37 indexed citations
9.
Uchida, Akifumi, Tomohiro Kumamoto, Kazuhito Hatanaka, et al.. (2017). Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma. BMC Pulmonary Medicine. 17(1). 195–195. 5 indexed citations
10.
Kumamoto, Tomohiro, Naohiko Seki, Hiroko Mataki, et al.. (2016). Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma. International Journal of Oncology. 49(5). 1870–1880. 46 indexed citations
12.
Kuroda, Naoto, Kaori Inoue, Masahiko Ohara, et al.. (2011). Smear cytology findings of large cell neuroendocrine carcinoma of the uterine cervix. Diagnostic Cytopathology. 41(7). 636–639. 12 indexed citations
13.
Kuroda, Naoto, et al.. (2010). Solid papillary carcinoma of the breast: imprint cytological and histological findings. Medical Molecular Morphology. 43(1). 48–52. 10 indexed citations
14.
Kuroda, Naoto, Shoichiro Nakamura, Kaori Inoue, et al.. (2009). Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. Medical Molecular Morphology. 42(4). 236–238. 27 indexed citations
16.
Kuroda, Naoto, Kaori Inoue, Masahiko Ohara, et al.. (2008). Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinomas. Medical Molecular Morphology. 41(2). 117–120. 14 indexed citations
17.
Kuroda, Naoto, Kaori Inoue, Masahiko Ohara, et al.. (2008). Significance of D2-40 expression in the diagnosis of gastrointestinal stromal tumor. Medical Molecular Morphology. 41(2). 109–112. 9 indexed citations
18.
Kuroda, Naoto, et al.. (2007). Large cell neuroendocrine carcinoma of the lung with calcification and expression of osteopontin. Medical Molecular Morphology. 40(4). 218–220. 4 indexed citations
19.
Kuroda, Naoto, Shinichi Iwamura, Masahiko Ohara, et al.. (2007). Anaplastic carcinoma of the pancreas with rhabdoid features and hyaline globule-like structures. Medical Molecular Morphology. 40(3). 168–171. 13 indexed citations
20.
Kuroda, Naoto, et al.. (2006). Lung adenocarcinoma with a micropapillary pattern: a clinicopathological study of 25 cases. Apmis. 114(5). 381–385. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026